Investigating into anti-cancer potential of lycopene: Molecular targets

Wang Jia Qi1, Wang Shi Sheng2, Chu Peng3

  • 1Department of Plastic and Reconstructive Surgery, The First Bethune Hospital of Jilin University, No. 71, Xin Min Street, Changchun 130021, Jilin, China.

Insights

Lycopene, a tomato pigment, shows potent antioxidant and anticancer properties. It inhibits tumor development by affecting cell proliferation, apoptosis, and metastasis through various molecular pathways, suggesting a role in cancer prevention.

Area of Science:

  • Nutritional Biochemistry
  • Molecular Oncology
  • Phytochemistry

Background:

  • Lycopene, the primary pigment in tomatoes, is a potent antioxidant carotenoid with unique chemical properties.
  • Despite its antioxidant capacity, lycopene has received limited research attention until recently.
  • Emerging research highlights lycopene's potential anticancer effects beyond its antioxidant and detoxification roles.

Purpose of the Study:

  • To review the latest scientific literature on lycopene's anticancer mechanisms.
  • To identify the molecular targets and pathways through which lycopene inhibits carcinogenesis.
  • To assess lycopene's potential as a functional pigment in cancer prevention.

Main Methods:

  • Comprehensive literature search of scientific databases (PubMed, Embase, Web of Science, Google Scholar) up to October 2020.
  • Screening of retrieved citations for relevance to lycopene's anticancer activities and mechanisms.
  • Synthesis of findings regarding lycopene's effects on tumor development and molecular pathways.

Main Results:

  • Lycopene demonstrates significant anticancer effects by inhibiting cell proliferation, cell cycle progression, apoptosis, invasion, angiogenesis, and metastasis.
  • Its mechanisms involve regulating key signal transduction pathways, including PI3K/Akt.
  • Lycopene modulates insulin-like growth factors, suppresses sex steroid hormone activity, alters gene expression, and affects mitochondrial function.

Conclusions:

  • Lycopene exhibits promising functional properties as a natural pigment with significant anticancer potential.
  • Its molecular mechanisms target critical aspects of tumor development.
  • Further research supports lycopene's association with a decreased risk of various cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K